A synthetic peptide vaccine consisting of amino acids 206 through 214 of the melanoma-associated antigen tyrosinase. Vaccination with TYROSINASE_206-214 may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for tyrosinase, resulting in decreased tumor growth. (NCI04) [ ]